Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography

Netherlands Heart Journal

Volumn 18, Issue 2, 2010, Pages 72-77

  Tan, E S ^a   Van Der Vleuten, P A ^a   Jessurun, G A J ^a   Tio, R A ^a   Zijlstra, F ^a   Van Gelder, I C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Body surface potential mapping; Contrast media; Coronary angiography; Ventricular function, left

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BIPLANE LEFT VENTRICULAR CONTRAST ANGIOGRAPHY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ELECTROMECHANICAL ENDOCARDIAL MAPPING; END DIASTOLIC VOLUME; FEMALE; FUNCTIONAL ASSESSMENT; GLOBAL LEFT VENTRICULAR FUNCTION; HEART CATHETERIZATION; HEART FUNCTION TEST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE FUNCTION; HUMAN; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION;

EID: 77949536429     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03091741     Document Type: Article

References (16)

1. Van der Vleuten PA, Rasoul S, Huurnink W, Van der Horst IC, Slart RH, Reiffers S, et al. The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention. BMC Cardiovasc Disord. 2008;8:4.
2. Moise A, Bourassa MG, Theroux P, Taeymans Y, Pasternac A, Campeau L, et al. Prognostic significance of progression of coronary artery disease. Am J Cardiol. 1985;55:941-6.
3. Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR Jr, Chaitman BR, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645-57.
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-6.
5. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294-302.
6. Beeres SL, Bax JJ, Dibbets-Schneider P, Stokkel MP, Fibbe WE, van der Wall EE, et al. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol. 2007;100:1094-8.
7. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210-21.
8. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451:937-42.
9. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111: 2198-202.
10. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol. 2003;42:2063-9.
11. Vale PR, Losordo DW, Milliken CE, McDonald MC, Gravelin LM, Curry CM, et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation. 2001;103:2138-43.
12. Tio RA, Tkebuchava T, Scheuermann TH, Lebherz C, Magner M, Kearny M, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther. 1999;10:2953-60.
13. Grothues F, Wolfram O, Fantoni C, Boenigk H, Gotte A, Tempelmann C, et al. Volume measurement by CARTO compared with cardiac magnetic resonance. Europace. 2006;8:37-41.
14. Van Langenhove G, Hamburger JN, Smits PC, Albertal M, Onderwater E, Kay IP, et al. Evaluation of left ventricular volumes and ejection fraction with a nonfluoroscopic endoventricular three-dimensional mapping technique. Am Heart J. 2000;140:596-602.
15. Hirsch A, Nijveldt R, Van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, et al. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial - a prospective, multicenter, randomized trial. Am Heart J. 2006;152:434-41.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-10.